Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.

Ultragenyx and partner Mereo BioPharma’s brittle bone disease trial will continue. Investors had wanted data good enough to ...

Sonnet to merge with crypto-backed firm, forming Hyperliquid Strategies with $888 million in assets, plus HYPE blockchain ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake ...

Sana Biotechnology, Inc. (NASDAQ:SANA) is among the fundamentally strong penny stocks to invest in. Morgan Stanley has ...

The industry of biotech is a great place to look for such stocks since so many of these companies are developing cutting-edge ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

Between Casgevy's long-term potential and the company's innovative pipeline, CRISPR Therapeutics could eventually recover and ...

Discover why IBB's focused approach makes it preferable to XBI. Learn about their objectives, diversification, and ...

Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.

Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.

Anbio Biotechnology (NASDAQ:NNNN)’s NASDAQ debut has garnered strong investor interest, resulting in a nearly 600% surge from ...